002603.SZ · 以岭药业
China A-shares · RS rating 62 · As of 2026-10-14
| Price | 15.07 CNY |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 57 / 49 / 61 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 15 / 24 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -33.0% |
| Distance from 52-week high | +28.4% |
| Market cap (USD) | $3.9B |